Trifluoroacetic acid → HCID 58292903, Verbindung

HRID 511383Notizen

Reaktionsgleichung

Reaktionsgleichung von HRID 511383
Cl[C:2]1[N:7]=[C:6]([NH:8][C:9]2[CH:18]=[CH:17][CH:16]=[CH:15][C:10]=2[C:11]([NH:13][CH3:14])=[O:12])[C:5]([C:19]([F:22])([F:21])[F:20])=[CH:4][N:3]=1.[NH2:23][C:24]1[CH:29]=[CH:28][C:27]([CH:30]([P:32](=[O:39])([O:36][CH2:37][CH3:38])[O:33][CH2:34][CH3:35])[OH:31])=[CH:26][CH:25]=1.[C:40](O)([C:42](F)(F)F)=O>CCO>[CH2:40]([O:31][CH:30]([P:32](=[O:39])([O:33][CH2:34][CH3:35])[O:36][CH2:37][CH3:38])[C:27]1[CH:28]=[CH:29][C:24]([NH:23][C:2]2[N:7]=[C:6]([NH:8][C:9]3[CH:18]=[CH:17][CH:16]=[CH:15][C:10]=3[C:11](=[O:12])[NH:13][CH3:14])[C:5]([C:19]([F:22])([F:21])[F:20])=[CH:4][N:3]=2)=[CH:25][CH:26]=1)[CH3:42]

Komponenten

5

Reaktionsbedingungen

Temperatur
105 °C

Versuchsvorschrift

Under N2, a solution of 2-{[2-chloro-5-(trifluoromethyl)pyrimidin-4-yl]amino}-N-methylbenzamide (40.0 mg, 0.12 mmol) and diethyl [(4-aminophenyl)(hydroxy)methyl]-phosphonate (37.6 mg, 0.15 mmol) in a mixture of TFA (28 uL, 0.36 mmol) and EtOH (0.5 mL) was stirred at 105° C. for 45 min in a Biotage microwave reactor. The solvents were removed under reduced pressure and to the residue was added sat. NaHCO3 (aq) (2 mL) and DCM (5 mL). Layers were separated and the aqueous layer was extracted with DCM (3×5 mL). The combined organic phases were dried over MgSO4, concentrated, and purified by silica gel chromatography (5% 7 N NH3 in MeOH in DCM) to afford the desired product as a white-colored solid (8.4 mg, yield: 12%). 1H NMR (CD3OD, 400 MHz): δ=1.22 (dt, J=0.8, 7.6 Hz, 6 H), 1.30 (t, J=7.2 Hz, 3 H), 2.90 (s, 3 H), 3.47-3.57 (m, 2 H), 3.95-4.15 (m, 4 H), 4.72 (d, J=16.0 Hz, 1 H), 7.18 (dt, J=1.2, 7.6 Hz, 1 H), 7.35 (dd, J=2.0, 8.4 Hz, 2 H), 7.49 (dd, J=1.6, 8.8 Hz, 1 H), 7.63-7.65 (m, 3 H), 8.34 (s, 1 H), 8.45 (m, 1 H). MS (ES+): m/z 582.17 [MH+]. HPLC: tR=3.44 min (OpenLynx, polar—5 min).

Aufarbeitung

  1. customThe solvents were removed under reduced pressure and to the residue
  2. additionwas added sat. NaHCO3 (aq) (2 mL) and DCM (5 mL)
  3. customLayers were separated
  4. extractionthe aqueous layer was extracted with DCM (3×5 mL)
  5. dry with materialThe combined organic phases were dried over MgSO4
  6. concentrationconcentrated
  7. custompurified by silica gel chromatography (5% 7 N NH3 in MeOH in DCM)

Quellen und Nachweise

ORD-Eintrag
ord-2bde4af5eaba47cf95fef7e2d953b94b
Quelldatensatz
uspto-grants-2015_08
Patentnummer
US09096624B2

Notizen zur Reaktion

Wird geladen…